1. Suntharalingham JP, Buonocore F, Duncan AJ, Achermann JC. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab. 2015; 29:607–19.
Article
2. Landau Z, Hanukoglu A, Sack J, Goldstein N, Weintrob N, Eliakim A, et al. Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations. Clin Endocrinol (Oxf). 2010; 72:448–54.
3. Poyrazoglu S, Saka N, Agayev A, Yekeler E. Prevalence of testicular microlithiasis in males with congenital adrenal hyperplasia and its association with testicular adrenal rest tumors. Horm Res Paediatr. 2010; 73:443–8.
Article
4. Backus ML, Mack LA, Middleton WD, King BF, Winter TC 3rd, True LD. Testicular microlithiasis: imaging appearances and pathologic correlation. Radiology. 1994; 192:781–5.
Article
5. Phelan JK, McCabe ER. Mutations in NR0B1 (DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenita. Hum Mutat. 2001; 18:472–87.
6. Lin L, Gu WX, Ozisik G, To WS, Owen CJ, Jameson JL, et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. J Clin Endocrinol Metab. 2006; 91:3048–54.
Article
7. Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF Jr, Jameson JL. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest. 1996; 98:1055–62.
Article
8. Seminara SB, Achermann JC, Genel M, Jameson JL, Crowley WF Jr. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab. 1999; 84:4501–9.
9. Doherty FJ, Mullins TL, Sant GR, Drinkwater MA, Ucci AA Jr. Testicular microlithiasis. A unique sonographic appearance. J Ultrasound Med. 1987; 6:389–92.
Article
10. Priebe CJ Jr, Garret R. Testicular calcification in a 4-year-old boy. Pediatrics. 1970; 46:785–8.
Article
11. Goede J, Hack WW. Clinical aspects of testicular microlithiasis in boys: a review. J Pediatr Urol. 2012; 8:459–69.
Article
12. Yesil S, Tanyildiz HG, Sahin G. How should we monitor boys with testicular microlithiasis? Pediatr Hematol Oncol. 2016; 33:171–7.
Article
13. Kocaoğlu M, Bozlar U, Bulakbaşi N, Sağlam M, Uçöz T, Somuncu I. Testicular microlithiasis in pediatric age group: ultrasonography findings and literature review. Diagn Interv Radiol. 2005; 11:60–5.
14. Yu MK, Jung MK, Kim KE, Kwon AR, Chae HW, Kim DH, et al. Clinical manifestations of testicular adrenal rest tumor in males with congenital adrenal hyperplasia. Ann Pediatr Endocrinol Metab. 2015; 20:155–61.
Article
15. Aizenstein RI, DiDomenico D, Wilbur AC, O'Neil HK. Testicular microlithiasis: association with male infertility. J Clin Ultrasound. 1998; 26:195–8.
Article
16. Meachem SJ, Nieschlag E, Simoni M. Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol. 2001; 145:561–71.
Article
17. Lam DL, Gerscovich EO, Kuo MC, McGahan JP. Testicular microlithiasis: our experience of 10 years. J Ultrasound Med. 2007; 26:867–73.
18. Miller FN, Rosairo S, Clarke JL, Sriprasad S, Muir GH, Sidhu PS. Testicular calcification and microlithiasis: association with primary intra-testicular malignancy in 3,477 patients. Eur Radiol. 2007; 17:363–9.
Article
19. Silveri M, Bassani F, Colajacomo M, Orazi C, Adorisio O. Management and follow-up of pediatric asymptomatic testicular microlithiasis: are we doing it well? Urol J. 2011; 8:287–90.